Among patients with limited-stage small cell lung cancer, the benefits of consolidation Imfinzi were seen across a number of ...

AstraZeneca Pharma India has received approval from the CDSO for the import, sale, and distribution of Durvalumab.

AstraZeneca topped the analyst consensus for net revenue and matched the analyst consensus for core EPS in Q2. See why I ...

Astrazeneca Pharma India has received CDSO's (Central Drugs Standard Control Organisation) nod for the import of Durvalumab ...

This surge came after the company announced approval to import and distribute Durvalumab (Imfinzi) infusion in two dosages.

Bengaluru: AstraZeneca Pharma India Limited has received permission to import for sale and distribution of Durvalumab 120 ...

The stock is trading above its 5-day, 10-day, 20-day, 30-day, 50-day, 100-day, 150-day, and 200-day simple moving averages ...

According to GLOBOCAN 2022 data, lung cancer remains the fourth most common cause of cancer-related mortality in India.

IST, the barometer index, the S&P BSE Sensex added 96.44 points or 0.11% to 85,025.05. The Nifty 50 index rose 29 points or 0.11% to 25,968.05.

Indian shares were flat to slightly higher on Tuesday, with metal, oil/gas and power stocks pacing the gainers. The benchmark ...

The company has received approval to import, sell, and distribute Durvalumab Solution for infusion (Imfinzi) from the Central Drugs Standard Control Organisation, Directorate General of Health ...

Billionaire investor George Soros became nearly a household name in the early 1990’s by shorting the British pound and making ...